We are live on ! Find out more
OBGC

O'Brien Greene & Co Portfolio holdings

AUM $353M
1-Year Est. Return 30.94%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+30.94%
3 Year Est. Return
+79.57%
5 Year Est. Return
+109.64%
10 Year Est. Return
AUM
$274M
AUM Growth
-$5.99M
Cap. Flow
-$1.31M
Cap. Flow %
-0.48%
Top 10 Hldgs %
30.97%
Holding
141
New
5
Increased
67
Reduced
13
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Healthcare 14.26%
3 Financials 11.11%
4 Materials 9.37%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
126
Vodafone
VOD
$36.4B
-15,419
Closed -$264K

Similar funds

O'Brien Greene & Co's Q3 2021 Portfolio in Review

As of Q3 2021, O'Brien Greene & Co held 141 positions worth $274M, down 2.1% from $280M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

O'Brien Greene & Co's Q3 2021 filing shows 5 new, 67 increased, 13 reduced and 8 closed positions. Its largest new stake was PLx Pharma Inc. Common Stock: 62,340 shares worth $1.2M. The largest sale was Dollar Tree, an estimated $5.63M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • O'Brien Greene & Co's largest Q3 2021 buy was PLx Pharma Inc. Common Stock: 62,340 shares worth $1.2M.
  • O'Brien Greene & Co added most to Medtronic in Q3 2021, an estimated $4.34M increase.
  • O'Brien Greene & Co's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $4.54M.
  • O'Brien Greene & Co fully exited Dollar Tree in Q3 2021, selling an estimated $5.63M.
  • O'Brien Greene & Co's ten largest holdings make up 31% of its $274M portfolio in Q3 2021.
  • O'Brien Greene & Co opened 5 new positions and closed 8 in Q3 2021.
  • O'Brien Greene & Co's portfolio value fell 2.1% quarter-over-quarter to $274M.

Based on O'Brien Greene & Co's 13F filing for Q3 2021, filed 12 Nov 2021.